CALL/MERCK & CO./100/0.1/20.06.25 | Market Closed - BOERSE MUENCHEN 14:26:28 2024-06-25 EDT | ||
| 3.5 EUR | +2.22% |
|
| Current month | +25.76% | ||
| 1 month | +11.50% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-25 | 3.5 | +2.22% |
| 24-06-24 | 3.424 | +5.81% |
| 24-06-21 | 3.236 | -0.92% |
| 24-06-20 | 3.266 | +7.43% |
| 24-06-19 | 3.04 | -1.07% |
Real-time BOERSE MUENCHEN
Last update June 25, 2024 at 02:26 pm
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | Goldman Sachs |
| WKN | GP7RDF |
| ISIN | DE000GP7RDF6 |
| Date issued | 2023-07-07 |
| Strike | 100 $ |
| Maturity | 2025-06-20 (360 Days) |
| Parity | 10 : 1 |
| Emission price | 2.08 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 3.597 € |
|---|---|
| Lowest since issue | 1.11 € |
| Spread | 0.05 € |
| Spread % | 1.42% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
132.9
USD
Average target price
142.7
USD
Spread / Average Target
+7.34%
- Stock Market
- Warrants
- Warrant
